MATTERS develops educational materials for partners and community members to utilize across our networks. Explore our resource library below and use the search function to find what you’re looking for even faster.
Understanding the cycle of addiction can help when addressing substance use disorder.
Drugs like fentanyl are contaminating stimulants across the United States.
Fentanyl is a potent, synthetic opioid that is contaminating other drugs in the U.S. drug supply.
Xylazine is a potent veterinary tranquilizer that is contaminating opioids across the U.S.
Tianeptine is an emerging risk to public health due to its potential for misuse and widespread availability.
Reduce stigma against people who use drugs (PWUD) by adjusting your language.
Medetomidine is a potent sedative-analgesic contributing to a recent wave of overdoses.
Dispel common myths and misconceptions around fentanyl exposure risks.
Syringe Services are an example of evidence-based harm reduction strategies.
Resources for Prescribers
Navigate the documents below to review current prescribing guidelines, exemptions, and frequently asked questions.
The DEA released instructions on how to request an extension for practitioners administering or dispensing certain medications for opioid use disorder (MOUD).
MATTERS has developed a patient notice for opioid and sedative prescribing to help them understand the risks of misusing these substances.
MATTERS provides guidelines for opioid and sedative prescribing for new providers or those who are new to prescribing controlled substances such as buprenorphine.
Since the repeal of the X-Waiver, many providers are eligible to prescribe buprenorphine to treat opioid use disorder. Learn more about prescribing requirements by navigating our frequently asked questions.